CoChat

Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?

Mamo, John C. L., Watts, Gerald F., Barrett, P. Hugh R., Smith, Darrin, James, Anthony P., Pal, Sebely · 2001 · American Journal of Physiology-Endocrinology and Metabolism
Cited by 112

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Postprandial lipemia after an oral fat challenge was studied in middle-aged men with visceral obesity. The two groups had similar plasma cholesterol levels, but obese subjects had higher levels of plasma triglyceride and reduced amounts of high-density cholesterol. Fasting plasma insulin was fourfold greater in obese subjects because of concomitant insulin resistance, with a calculated HOMA score of 3.1 ± 0.6 vs. 0.8 ± 0.2, respectively. Plasma apolipoprotein B 48(apoB 48) and retinyl palmitate (RP) after an oral fat challenge were used to monitor chylomicron metabolism. Compared with lean subjects, the fasting concentration of apoB 48 was more than twofold greater in obese individuals, suggestive of an accumulation of posthydrolyzed particles. After the oral lipid load, the incremental areas under the apoB 48 and RP curves (IAUC) were both significantly greater in obese subjects (apoB 48: 97 ± 17 vs. 44 ± 12 μg · ml−1· h; RP: 3,120 ± 511 vs. 1,308 ± 177 U · ml−1· h, respectively). A delay in the conversion of chylomicrons to remnants probably contributed to postprandial dyslipidemia in viscerally obese subjects. The triglyceride IAUC was 68% greater in obese subjects (4.7 ± 0.6 vs. 2.8 ± 0.8 mM · h, P< 0.06). Moreover, peak postprandial triglyceride was delayed by ∼2 h in obese subjects. The reduction in triglyceride lipolysis in vivo did not appear to reflect changes in hydrolytic enzyme activities. Postheparin plasma lipase rates were found to be similar for lean and obese subjects. In this study, low-density lipoprotein (LDL) receptor expression on monunuclear cells was used as a surrogate marker of hepatic activity. We found that, in obese subjects, the binding of LDL was reduced by one-half compared with lean controls (70.9 ± 15.07 vs. 38.9 ± 4.6 ng LDL bound/μg cell protein, P = 0.02). Because the LDL receptor is involved in the removal of proatherogenic chylomicron remnants, we suggest that the hepatic clearance of these particles might be compromised in insulin-resistant obese subjects. Premature and accelerated atherogenesis in viscerally obese, insulin-resistant subjects may in part reflect delayed clearance of postprandial lipoprotein remnants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.2001.281.3.e626

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 33

  1. 10.1016/0002-9149(91)90856-G · DOI
  2. 10.1042/bj2760381 · DOI · Paper page
  3. 10.1002/(SICI)1096-9136(199711)14:11<942::AID-DIA500>3.0.CO;2-B · doi:10.1002/(sici)1096-9136(199711)14:11<942::aid-dia500>3.0.co;2-b
  4. Chen M, 1994, J Lipid Res, 35, 1918, 10.1016/S0022-2275(20)39938-7 · DOI · Paper page
  5. Cohn JS., 1998, Can J Cardiol, 14, 18B
  6. 10.1002/(SICI)1096-9136(199609)13:9<816::AID-DIA183>3.0.CO;2-L · DOI
  7. Després JP, 1990, Atherosclerosis, 10, 497
  8. 10.2337/diab.42.10.1474 · DOI
  9. 10.1097/00041433-199510000-00011 · DOI · Paper page
  10. 10.1016/0021-9150(94)90085-X · DOI · Paper page
  11. 10.1016/0026-0495(90)90249-C · DOI
  12. 10.1210/jcem-71-4-1041 · DOI · Paper page
  13. 10.1016/0005-2760(92)90298-A · doi:10.1016/0005-2760(92)90298-a
  14. 10.1046/j.1365-2362.1998.00284.x · DOI · Paper page
  15. 10.1007/BF00398049 · DOI
  16. 10.2337/diab.33.4.333 · DOI · Paper page
  17. McConathy WJ, 1992, J Lipid Res, 33, 995, 10.1016/S0022-2275(20)41415-4 · DOI · Paper page
  18. Mekki N, 1999, J Clin Endocrinol Metab, 84, 184
  19. 10.1038/sj.ijo.0801372 · DOI
  20. Nakao Y, 1993, Nippon Naibumpi Gakkai Zasshi-Folia Endocrinol Jpn, 69, 670
  21. 10.1152/ajpendo.1995.268.4.E588 · DOI · Paper page
  22. Pouiliot MC, 1990, J Lipid Res, 31, 1023, 10.1016/S0022-2275(20)42742-7 · DOI · Paper page
  23. 10.1172/JCI117213 · DOI · Paper page
  24. 10.2337/diab.36.3.327 · DOI
  25. 10.1038/sj.ijo.0800602 · DOI
  26. 10.1016/0021-9150(93)90267-X · DOI
  27. 10.1038/sj.ijo.0800604 · DOI
  28. 10.1177/000456329703400210 · DOI · Paper page
  29. 10.2337/diab.30.2.S1 · DOI · Paper page
  30. 10.1111/j.1432-1033.1988.tb14084.x · DOI · Paper page
  31. Windler E, 1985, J Lipid Res, 26, 556, 10.1016/S0022-2275(20)34342-X · DOI · Paper page
  32. Wu JH, 2000, J Formos Med Assoc, 99, 367
  33. 10.1016/0026-0495(91)90204-A · doi:10.1016/0026-0495(91)90204-a

Cited by

See all 112

Metadata

Authors
Mamo, J. C. L., Watts, G. F., Barrett, P. H. R., Smith, D., James, A. P., & Pal, S.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2001-09-01
Volume
281
Issue
3
Pages
E626-E632
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W1961362138
Cited by
112
References
4
FWCI
4.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? https://app.cochat.ai/papers/10.1152/ajpendo.2001.281.3.e626
The paper
Mamo, J. C. L., Watts, G. F., Barrett, P. H. R., Smith, D., James, A. P., & Pal, S. (2001). Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.2001.281.3.e626

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.